openPR Logo
Press release

Mucormycosis Market Set to Surge Significantly During 2026

09-07-2018 09:38 AM CET | Health & Medicine

Press release from: Transparency Market Research

Mucormycosis Market Set to Surge Significantly During 2026

Mucormycosis is a rapidly progressive and life-threatening invasive fungal disease with high morbidity and mortality rates despite treatment. It primarily affects immunocompromised patients such as those with organ and bone marrow transplantation and hematological malignancy and patients with diabetes, cancer, neutropenia, and skin trauma. In rare cases it also affects immunocompetent patients. Mucormycosis is caused by a group of molds called mucormycetes. Inhaling the spores of the molds can affect the lungs and sinuses, and the fungus may also invade the skin through wounds such as cuts, burns, scrapes, or other types of skin trauma.

Read Report Overview:

Although rare, mucormycosis affects around 0.06 to 0.16 people per 10,000 globally each year. The threat of mucormycosis is growing with an increase in the population at risk, comprising mainly immunocompromised and critically ill patients. Mortality rates of 17% to 66% in patients with mucormycosis have been reported in recent studies. However, these can rise to over 90% in cases of disseminated infections.

The mucormycosis market is mainly driven by increase in occurrence of fungal infections, rise in incidence of immunological diseases, and greater access to a wide range of products. Furthermore, increase in government support for research & development and rise in awareness about fungal infections are fuelling the mucormycosis market. However, high cost of treatment is a major restraining factor for the mucormycosis market. The cost of treatment for mucormycosis is significant, with total costs much higher for mucormycosis patients when compared with matched controls at high risk of mucormycosis infection. Amphotericin B (AMB) formulations are the only licensed antifungal therapy known so far for mucormycosis, out of which the liposomal AMB (L-AMB) is widely used in Europe as the standard of care. However, L-AMB carries a risk of renal toxicity, which is related to the reduction of doses and finally discontinuations. Moreover, it is not available as an oral formulation. Thus, in order to fulfill unmet medical needs, more research is being carried out to develop new treatment methods for mucormycosis.

Request Brochure of Report:

The mucormycosis market can be segmented based on species, diagnosis method, treatment, end-user,and region. Based on species, the mucormycosis market can be categorized into Rhizopus, Cunninghamella, Rhizomucor, Saksenaea, Apophysomyces, Lichtheimia, Mucor, and others. In terms of diagnosis method, the mucormycosis market can be classified into magnetic resonance imaging (MRI), computed tomography (CT), tissue biopsy, and others. Based on treatment, the mucormycosis market can be segmented into surgery, amphotericin B therapy, antifungal drugs, and others. The antifungal drugs segment can be further divided into isavuconazole, posaconazole, voriconazole, flucytosine, fluconazole, and others. In terms of end-user, the mucormycosis market can be categorized into hospitals & clinics, research organization, medical institutes, and others.

Based on region, the mucormycosis market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds a significant share of the global mucormycosis market due to its advanced health care sector and a large patient population for mucormycosis. In the last few years, many antifungal drugs have lost their patients. For instance, Terbinafine products (Lamisil) lost their patient pool in 2017. As there is a limited number of oral preparations in the market, development and licensing of new drugs is a significant opportunity for the development of the market during the forecast period.

Request For TOC :

Europe holds a significant share of the global mucormycosis market. This is due to technological progressions in the area of surgical devices and rise in incidence of fungal infections. Governments of European countries have launched incentives schemes to boost the anti-infective drugs industry and reduce risk and cost for manufacturers. Another factor driving the mucormycosis market is the rising percentage of diabetes mellitus patients, mainly in the developed countries of Europe. The average prevalence rate of diabetes in Europe is around 9% of the adult population. The market in Asia Pacific is anticipated to expand at a rapid CAGR during the forecast period. This is due to various factors such as increase in prevalence of HIV and significant growth opportunities in the untapped market in emerging economies.

The key players in the global mucormycosis market are Abbott Laboratories, Biocon Limited, Cadila Pharmaceuticals Limited, Novartis AG, F. Hoffman La Roche, Merck Sharp and Dohme, Mylan Labs, Bristol Myers Squibb, Bayer AG, Lonza Group, Sanofi, Johnson & Johnson, Pfizer Inc., and Gilead Sciences.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mucormycosis Market Set to Surge Significantly During 2026 here

News-ID: 1226174 • Views: 246

More Releases from Transparency Market Research

Scaffolding Market is prophesied to rise at 6.1% of CAGR during the forecast per …
Global Scaffolding Market: Snapshot A temporary structure used to support the work crew and helps in transporting raw material at the time of construction, repair of building, maintenance, and other man-made structures is known as scaffolding. Scaffolding is widely used on sites to get access to heights and areas where it is hard to reach. In addition, scaffolding is used in adapted forms for grandstand seating, formwork and shoring, concert
Industrial Agitators Market to See Incredible Growth During 2019-2027
Global Industrial Agitators Market: Overview The global industrial agitators market is forecasted to be an evolving and upcoming industry. In the chemical, pharmaceutical, mineral and cosmetic industries, among many others, industrial agitators are used to mix several materials. The mixing process involves the use of high-performance, but low internal power consumption mechanical components. The agitators mix solids with fluids, liquid gases and liquids in a wide range of vertical
Automotive telematics market Progresses for Huge Profits During 2019-2027
High Demand for Improved Connectivity and Intelligence in Vehicles to Fuel Market Growth The automotive sector is no stranger to innovations, and with the advent of novel technologies such as the Internet of Things (IoT), automotive manufacturers are in the pursuit of integrating IoT into vehicles during the manufacturing stage. Owing to noteworthy advancements in technology, a broad range of telematics services and devices has entered the automotive telematics market. Furthermore,
Warewashing Professional Equipment Market is Projected to Reach US$ 6.94 Bn by 2 …
Warewashing professional equipment is used to wash glassware, pots, dishes, and utensils that are utilized to serve or prepare food. It primarily involves the following four steps: Washing, rinsing, sanitizing, and drying. Modern warewashing professional equipment contains advanced technology components and products integrated with IoT, which offers several features that make washing more convenient. This increases the attractiveness of warewashing professional equipment among consumers. An increasing number of hotels and

All 5 Releases

More Releases for Europe

Synthetic Biology Market – Europe
Synthetic Biology Market Europe is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Synthetic biology has expanded into various interdisciplinary fields that may be defined as the combination of artificial design and engineering to produce biological systems, chemicals or living organisms. Synthetic biology is also used for improving applications
Europe Wooden Doors Market
Europe Wooden Doors Market This report studies the Wooden Doorsmarket status and outlook of Europe and major countries, from angles of players, countries, product types and end industries; this report analyzes the top players in Europe and major countries, and splits the Wooden Doors market by product type and applications/end industries. The global Wooden Doors market is valued at XX million USD in 2018 and is expected to reach XX million
Europe Radiotherapy Market
The Europe Radiotherapy Market research report consists of a primary and secondary research along with an in-depth analysis of the quantitative and qualitative aspects by the expert industry analysts and professionals, leading management bodies, to gain a profound insight of the industry as well as the industry performance. The Europe Radiotherapy Market report presents a lucid picture of the current industry landscape, including the historical and projected market size, based
Europe Business Assembly
The Europe Business Assembly (EBA) is an international corporation for the evolution and implementation of economic and social development. The company was established in April 2000 and its history shows a plethora of promising initiatives, creative growth and professional victories. EBA’s activity demonstrates the capabilities and power of professional partnership. The year 2000 saw the beginning and the foundation of EBA with the signing of the memorandum of cooperation and
Smartsourcing in Eastern Europe
In 2008 the outsourcing business of Eastern Europe was estimated at nearly $2 billion, representing just a tiny fraction of the global IT outsourcing market, estimated at about $386 billion. According to the Gartner Dataquest predictions, in the next four years Eastern Europe is expected to outstrip the rest of the offshore market concentrated mainly in the “classical” locations like India. By 2010 Eastern Europe’s IT outsourcing market share is
Home Control conquers Europe
European Home Control Summit attracts participation from leading International companies and organizations 29. February 2008 - Copenhagen/Frankfurt - The first European Wireless Home Control Summit on 9 April 2008, taking place parallel to Light + Building, features leading companies such as Merten, Horstmann, Danfoss, and market researcher Parks Associates as well as publicly funded organizations like the Danish Energy Saving Trust (DEST) presenting the newest trends, products and market strategies pertaining